442 related articles for article (PubMed ID: 19913918)
61. Synthesis, characterization, HSA/DNA interactions and antitumor activity of new [Ru(η
Đukić MB; Jeremić MS; Filipović IP; Klisurić OR; Kojić VV; Jakimov DS; Jelić RM; Onnis V; Matović ZD
J Inorg Biochem; 2020 Dec; 213():111256. PubMed ID: 32980642
[TBL] [Abstract][Full Text] [Related]
62. Rh(II) and Rh(I) two-legged piano-stool complexes: structure, reactivity, and electronic properties.
Dixon FM; Masar MS; Doan PE; Farrell JR; Arnold FP; Mirkin CA; Incarvito CD; Zakharov LN; Rheingold AL
Inorg Chem; 2003 May; 42(10):3245-55. PubMed ID: 12739966
[TBL] [Abstract][Full Text] [Related]
63. Induction of cell cycle arrest and apoptosis by ruthenium complex cis-(dichloro)tetramineruthenium(III) chloride in human lung carcinoma cells A549.
de Lima AP; Pereira Fde C; Vilanova-Costa CA; Soares JR; Pereira LC; Porto HK; Pavanin LA; Dos Santos WB; Silveira-Lacerda Ede P
Biol Trace Elem Res; 2012 Jun; 147(1-3):8-15. PubMed ID: 22144016
[TBL] [Abstract][Full Text] [Related]
64. DNA-binding, photocleavage, cytotoxicity in vitro, apoptosis and cell cycle arrest studies of symmetric ruthenium(II) complexes.
Xie YY; Huang HL; Yao JH; Lin GJ; Jiang GB; Liu YJ
Eur J Med Chem; 2013 May; 63():603-10. PubMed ID: 23567948
[TBL] [Abstract][Full Text] [Related]
65. Organometallic Ru(II), Rh(III) and Re(I) complexes of sterane-based bidentate ligands: synthesis, solution speciation, interaction with biomolecules and anticancer activity.
Pivarcsik T; Kiss MA; Rapuš U; Kljun J; Spengler G; Frank É; Turel I; Enyedy ÉA
Dalton Trans; 2024 Mar; 53(11):4984-5000. PubMed ID: 38406993
[TBL] [Abstract][Full Text] [Related]
66. Effect of ancillary ligands on the topoisomerases II and transcription inhibition activity of polypyridyl ruthenium(II) complexes.
Chen X; Gao F; Zhou ZX; Yang WY; Guo LT; Ji LN
J Inorg Biochem; 2010 May; 104(5):576-82. PubMed ID: 20167375
[TBL] [Abstract][Full Text] [Related]
67. Phenanthroline ligands are biologically more active than their corresponding ruthenium(II) arene complexes.
Valladolid J; Hortigüela C; Busto N; Espino G; Rodríguez AM; Leal JM; Jalón FA; Manzano BR; Carbayo A; García B
Dalton Trans; 2014 Feb; 43(6):2629-45. PubMed ID: 24327227
[TBL] [Abstract][Full Text] [Related]
68. Bis(4,7-dimethyl-1,10-phenanthroline) sulfatooxovanadium(IV) as a novel apoptosis-inducing anticancer agent.
Narla RK; Dong Y; D'Cruz OJ; Navara C; Uckun FM
Clin Cancer Res; 2000 Apr; 6(4):1546-56. PubMed ID: 10778988
[TBL] [Abstract][Full Text] [Related]
69. From hydrolytically labile to hydrolytically stable Ru(II)-arene anticancer complexes with carbohydrate-derived co-ligands.
Hanif M; Meier SM; Kandioller W; Bytzek A; Hejl M; Hartinger CG; Nazarov AA; Arion VB; Jakupec MA; Dyson PJ; Keppler BK
J Inorg Biochem; 2011 Feb; 105(2):224-31. PubMed ID: 21194622
[TBL] [Abstract][Full Text] [Related]
70. Insertion reactions of GaCp*, InCp* and In[C(SiMe3)3] into the Ru-Cl bonds of [(p-cymene)RuIICl2]2 and [Cp*RuIICl]4.
Cokoja M; Gemel C; Steinke T; Schroder F; Fischer RA
Dalton Trans; 2005 Jan; (1):44-54. PubMed ID: 15605146
[TBL] [Abstract][Full Text] [Related]
71. DNA binding and cytotoxicity of ruthenium(II) and rhenium(I) complexes of 2-amino-4-phenylamino-6-(2-pyridyl)-1,3,5-triazine.
Ma DL; Che CM; Siu FM; Yang M; Wong KY
Inorg Chem; 2007 Feb; 46(3):740-9. PubMed ID: 17257015
[TBL] [Abstract][Full Text] [Related]
72. Reactions of potent antitumor complex trans-[Ru(III)Cl4(indazole)2]- with a DNA-relevant nucleobase and thioethers: insight into biological action.
Egger A; Arion VB; Reisner E; Cebrián-Losantos B; Shova S; Trettenhahn G; Keppler BK
Inorg Chem; 2005 Jan; 44(1):122-32. PubMed ID: 15627368
[TBL] [Abstract][Full Text] [Related]
73. Novel half-sandwich Ru(II)-hydroxamate complexes: synthesis, characterization and equilibrium study in aqueous solution.
Buglyó P; Farkas E
Dalton Trans; 2009 Oct; (38):8063-70. PubMed ID: 19771370
[TBL] [Abstract][Full Text] [Related]
74. Chloro half-sandwich osmium(II) complexes: influence of chelated N,N-ligands on hydrolysis, guanine binding, and cytotoxicity.
Peacock AF; Habtemariam A; Moggach SA; Prescimone A; Parsons S; Sadler PJ
Inorg Chem; 2007 May; 46(10):4049-59. PubMed ID: 17441712
[TBL] [Abstract][Full Text] [Related]
75. Highly Cytotoxic Ruthenium(II)-Arene Complexes from Bulky 1-Pyrenylphosphane Ligands.
Brissos RF; Clavero P; Gallen A; Grabulosa A; Barrios LA; Caballero AB; Korrodi-Gregório L; Pérez-Tomás R; Muller G; Soto-Cerrato V; Gamez P
Inorg Chem; 2018 Dec; 57(23):14786-14797. PubMed ID: 30444630
[TBL] [Abstract][Full Text] [Related]
76. A [4+2] mixed ligand approach to ruthenium DNA metallointercalators [Ru(tpa)(N-N)](PF(6))(2) using a tris(2-pyridylmethyl)amine (tpa) capping ligand.
Kraft SS; Bischof C; Loos A; Braun S; Jafarova N; Schatzschneider U
J Inorg Biochem; 2009 Aug; 103(8):1126-34. PubMed ID: 19540597
[TBL] [Abstract][Full Text] [Related]
77. Selenoquinones stabilized by ruthenium(II) arene complexes: synthesis, structure, and cytotoxicity.
Dubarle-Offner J; Clavel CM; Gontard G; Dyson PJ; Amouri H
Chemistry; 2014 May; 20(19):5795-801. PubMed ID: 24668791
[TBL] [Abstract][Full Text] [Related]
78. Inhibition of cancer cell growth by ruthenium(II) arene complexes.
Morris RE; Aird RE; Murdoch Pdel S; Chen H; Cummings J; Hughes ND; Parsons S; Parkin A; Boyd G; Jodrell DI; Sadler PJ
J Med Chem; 2001 Oct; 44(22):3616-21. PubMed ID: 11606126
[TBL] [Abstract][Full Text] [Related]
79. Synthesis and characterization of molecular rectangles of half-sandwich p-cymene ruthenium complexes bearing oxamidato ligands.
Zhang WZ; Han YF; Lin YJ; Jin GX
Dalton Trans; 2009 Oct; (39):8426-31. PubMed ID: 19789798
[TBL] [Abstract][Full Text] [Related]
80. Synthesis, interaction with DNA, cytotoxicity, cell cycle arrest and apoptotic inducing properties of ruthenium(II) molecular "light switch" complexes.
Shobha Devi C; Anil Kumar D; Singh SS; Gabra N; Deepika N; Kumar YP; Satyanarayana S
Eur J Med Chem; 2013 Jun; 64():410-21. PubMed ID: 23665797
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
